Potency Estimates for Recombinant Factor IX in the One-Stage Clotting Assay Are Influenced by More Than Just the Choice of Activated Partial Thromboplastin Time Reagent

Haemophilia - United Kingdom
doi 10.1111/hae.13556
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Performance of a Recombinant Fusion Protein Linking Coagulation Factor IX With Recombinant Albumin in One-Stage Clotting Assays

Journal of Thrombosis and Haemostasis
MedicineHematology
2018English

Activated Partial Thromboplastin Time

English

Unfractionated Heparin Monitoring With Activated Partial Thromboplastin Time

Pathology
Forensic MedicinePathology
2020English

Implications of Deranged Activated Partial Thromboplastin Time for Anaesthesia and Surgery

Anaesthesia
AnesthesiologyPain Medicine
2018English

Monitoring of Unfractionated Heparin Using Activated Partial Thromboplastin Time

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2013English

Interlaboratory Agreement in the Monitoring of Unfractionated Heparin Using the Anti-Factor Xa-Correlated Activated Partial Thromboplastin Time

Journal of Thrombosis and Haemostasis
MedicineHematology
2009English

Partial Thromboplastin Time

Archives of Internal Medicine
1999English

Isolated Prolonged Activated Partial Thromboplastin Time and Contact Factor Deficiencies: Case Series and Management Review

Research and Practice in Anesthesiology – Open Journal
2016English

Evaluation of Activated Partial Thromboplastin Time (aPTT) Reagents for Application in Biomedical Diagnostic Device Development

International Journal of Laboratory Hematology
BiochemistryMedicineClinical BiochemistryHematology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy